Sekundære endepunkter inkluderede forandring i smerter, global rating af livskvalitet med EuroQoL - 5D, lungekræft- symptom skala, og forandringer i karnosfkys performance status.
64 Secondary end-points included change of pain, global rating of quality of life by EuroQoL-5D, Lung Cancer Symptom Scale, and changes in Karnosfky performance status.